|Articles|January 20, 2023
T Cell expansion in the DASbox® Mini Bioreactor System
Author(s)Eppendorf
This application note examines the suitability of BioBLU® 0.3c Single-Use Bioreactors and the DASbox Mini Bioreactor System in the long-term expansion of CD4+ T cells.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5